Adhera Therapeutics, Inc. (OTCPK: ATRX)
Health Care · Biotechnology · US
$—
— today · — 1Y
Adhera Therapeutics, Inc. (OTCPK: ATRX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.16K and employs 2 people.
trading between 0.00 and 0.01.
Tweenvest scores Adhera Therapeutics, Inc. across four factors: quality 19/100, value 44/100. Its strongest factor is value.
ATRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.16K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.31
- Dividend yield
- —
- Beta (5Y)
- 717.92
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.63M
- Employees
- 2
- Next earnings
- —
About Adhera Therapeutics, Inc.
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
- ISIN
- US00687E4061
- Listed since
- Dec 7, 1993
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Evelo Biosciences, Inc.OTCPK: EVLO | $1.90K | $0.00 | — |
| RegeneRx Biopharmaceuticals, Inc.OTCPK: RGRX | $1.66K | $— | — |
| Evolutionary Genomics, Inc.OTCPK: FNAM | $1.33K | $— | — |
| GlobeStar Therapeutics CorporationOTCPK: GSTC | $1.24K | $— | — |
| EV Biologics, Inc.OTCPK: YECO | $1.02K | $0.00 | -66.67% |
| eFFECTOR Therapeutics, Inc.OTCPK: EFTR | $941.00 | $0.00 | -75.00% |
| Proteonomix, Inc.OTCPK: PROT | $791.00 | $— | — |
| Pathfinder Cell Therapy, Inc.OTCPK: PFND | $667.00 | $— | — |
Figures last refreshed Oct 4, 2026.